These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 18779377)

  • 21. Population pharmacokinetics of infliximab in patients with ankylosing spondylitis.
    Xu Z; Seitz K; Fasanmade A; Ford J; Williamson P; Xu W; Davis HM; Zhou H
    J Clin Pharmacol; 2008 Jun; 48(6):681-95. PubMed ID: 18401017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics of idraparinux, a long-acting indirect factor Xa inhibitor: population pharmacokinetic analysis from Phase III clinical trials.
    Veyrat-Follet C; Vivier N; Trellu M; Dubruc C; Sanderink GJ
    J Thromb Haemost; 2009 Apr; 7(4):559-65. PubMed ID: 19187079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse effects of tenofovir use in HIV-infected pregnant women and their infants.
    Nurutdinova D; Onen NF; Hayes E; Mondy K; Overton ET
    Ann Pharmacother; 2008 Nov; 42(11):1581-5. PubMed ID: 18957630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients.
    Press RR; Ploeger BA; den Hartigh J; van der Straaten T; van Pelt J; Danhof M; de Fijter JW; Guchelaar HJ
    Ther Drug Monit; 2009 Apr; 31(2):187-97. PubMed ID: 19258929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients.
    Jaafar A; Séronie-Vivien S; Malard L; Massip P; Chatelut E; Tack I
    AIDS; 2009 Jan; 23(2):257-9. PubMed ID: 19098496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infliximab pharmacokinetics in inflammatory bowel disease patients.
    Ternant D; Aubourg A; Magdelaine-Beuzelin C; Degenne D; Watier H; Picon L; Paintaud G
    Ther Drug Monit; 2008 Aug; 30(4):523-9. PubMed ID: 18641542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.
    Psevdos G; Gonzalez E; Sharp V
    AIDS Read; 2009; 19(6):245-8. PubMed ID: 19642243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment.
    Bouillon-Pichault M; Jullien V; Azria E; Pannier E; Firtion G; Krivine A; Compagnucci A; Taulera O; Finkielsztejn L; Chhun S; Pons G; Launay O; Treluyer JM
    J Antimicrob Chemother; 2009 Jun; 63(6):1223-32. PubMed ID: 19389715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
    Rey D; Hoen B; Chavanet P; Schmitt MP; Hoizey G; Meyer P; Peytavin G; Spire B; Allavena C; Diemer M; May T; Schmit JL; Duong M; Calvez V; Lang JM
    J Antimicrob Chemother; 2009 Feb; 63(2):380-8. PubMed ID: 19036752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study.
    Fux CA; Rauch A; Simcock M; Bucher HC; Hirschel B; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Elzi L; Furrer H;
    Antivir Ther; 2008; 13(8):1077-82. PubMed ID: 19195333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of the selective serotonin 5-HT1A receptor partial agonist piclozotan.
    Mondick JT; Oo C; Patel D; Fujitani T; Shimizu K; Barrett JS
    Am J Ther; 2009; 16(2):106-15. PubMed ID: 19300037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient.
    Perrot S; Aslangul E; Szwebel T; Caillat-Vigneron N; Le Jeunne C
    J Clin Rheumatol; 2009 Mar; 15(2):72-4. PubMed ID: 19265350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of digoxin in Thai pediatric patients.
    Preechagoon Y; Somsaard P; Petcharattana S
    J Med Assoc Thai; 2009 Oct; 92(10):1324-35. PubMed ID: 19845241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
    Colom H; Farré R; Soy D; Peraire C; Cendros JM; Pardo N; Torrent M; Domenech J; Mangues MA
    Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tenofovir for the treatment of hepatitis B virus.
    Jenh AM; Thio CL; Pham PA
    Pharmacotherapy; 2009 Oct; 29(10):1212-27. PubMed ID: 19792994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal dysfunction and tenofovir toxicity in HIV-infected patients.
    Szczech LA
    Top HIV Med; 2008; 16(4):122-6. PubMed ID: 18838746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetics of amprenavir in HIV-1 patients with renal insufficiency].
    Janus N; Launay-Vacher V; Izzedine H; Karie S; Laville I; Deray G
    Med Mal Infect; 2007 Dec; 37(12):832-4. PubMed ID: 17997253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population.
    Kawuma AN; Wasmann RE; Sinxadi P; Sokhela SM; Chandiwana N; Venter WDF; Wiesner L; Maartens G; Denti P
    CPT Pharmacometrics Syst Pharmacol; 2023 Jun; 12(6):821-830. PubMed ID: 37013631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population Modeling Highlights Drug Disposition Differences Between Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in the Blood and Semen.
    Greene SA; Chen J; Prince HMA; Sykes C; Schauer AP; Blake K; Nelson JAE; Gay CL; Cohen MS; Dumond JB
    Clin Pharmacol Ther; 2019 Oct; 106(4):821-830. PubMed ID: 31002391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population Pharmacokinetics of Tenofovir in HIV-1-Uninfected Members of Serodiscordant Couples and Effect of Dose Reporting Methods.
    Lu Y; Goti V; Chaturvedula A; Haberer JE; Fossler MJ; Sale ME; Bangsberg D; Baeten JM; Celum CL; Hendrix CW
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5379-86. PubMed ID: 27353269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.